# Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

> **NCT00103181** · NA · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 4216 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** 3-dimensional conformal accelerated partial breast irradiation
- **RADIATION:** brachytherapy
- **RADIATION:** whole breast irradiation
- **RADIATION:** MammoSite or other single-entry intracavitary device

## Key facts

- **NCT ID:** NCT00103181
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 4216 (ACTUAL)
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103181, "Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00103181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*